Sleep in Hospitalized Children With Cancer: A Cross-Sectional Study

Chani Traube1,2, Lynne Rosenberg3, Francesca Thau3

  • 1Departments of Pediatrics, chr9008@med.cornell.edu.

Hospital Pediatrics
|October 30, 2020
PubMed

Insights

Most hospitalized children with cancer experience inadequate sleep. Hospital factors like noise, alarms, child worries, and benzodiazepines contribute to poor sleep, highlighting areas for potential intervention.

Area of Science:

  • Pediatric Oncology
  • Sleep Medicine
  • Clinical Research

Background:

  • Hospitalized children with cancer often face sleep disruption.
  • In-hospital sleep disturbances may negatively impact patient outcomes.

Purpose of the Study:

  • To characterize sleep quality and quantity in hospitalized pediatric cancer patients.
  • To evaluate the association between subjective and objective sleep measures.
  • To identify hospital-associated risk factors for poor sleep.

Main Methods:

  • Cross-sectional study involving 56 children (0-18 years) on a pediatric oncology ward.
  • Parental sleep questionnaires and actigraphy were used to assess sleep.
  • Data included demographics, clinical information, and hospital-associated factors.

Main Results:

  • 66% of participants reported inadequate sleep.
  • Actigraphy showed a median total sleep time of 477 minutes.
  • Noise, alarms, child's worries, and benzodiazepine use were linked to inadequate sleep.

Conclusions:

  • Inadequate sleep is prevalent in hospitalized children with cancer.
  • Subjective and objective sleep measures correlated well.
  • Modifiable hospital factors present targets for sleep improvement interventions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
132
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
151
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124